Evidence mapPaperPMID 42427145Full record

ReviewImmunological reviews2026

Modeling TCR-Epitope Recognition Specificity: What We Should Learn to Succeed.

David Gfeller, Julien Racle, Rita Ann Roessner

Abstract readReview
In one paragraph

Review in Immunological reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David GfellerDepartment of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-3952-0930
Julien RacleDepartment of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland.
Rita Ann RoessnerDepartment of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 320030-231333
6 · The paper itself

Abstract

T-cell recognition of infected or malignant cells is central to both spontaneous and therapy-induced cellular immune responses against pathogens and cancer. This recognition is elicited by the interaction between T-Cell Receptors (TCRs) and epitopes, which consist of antigenic peptides displayed on major histocompatibility complex molecules. TCR-epitope interactions are characterized by high diversity in TCR and epitope sequences and high structural flexibility in TCR loops. As a result, deciphering the rules of TCR-epitope recognition specificity and accurately predicting these interactions remains challenging. Here, we review the different strategies developed to predict TCR-epitope recognition, classify the principal computational frameworks, examine the data modalities on which they depend and discuss their current limitations. We then synthesize key conceptual insights that have emerged from recent research and outline how these lessons should inform the design of future experiments and next-generation computational tools.

Indexed as

Epitopes, T-LymphocyteModels, ImmunologicalReceptors, Antigen, T-CellT-LymphocytesAnimalsEpitope MappingHumansImmunoinformaticsProtein BindingEpitopes, T-LymphocyteReceptors, Antigen, T-Cellcomputational immunologymachine learningT‐cell epitope recognitionT‐cell receptor

Identifiers

PMID42427145
PMCPMC13351793

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.